About Us
HDT Bio is a Seattle-based clinical stage biopharmaceutical development company, founded in 2018 with a mission of creating novel technologies and products that harness the immune system’s response against a variety of disease conditions.
Multidisciplinary Team
HDT Bio’s multidisciplinary team brings extensive regulatory, business, scientific and clinical development experience needed to navigate the intricate process of bringing new products to market, from ideation to regulatory approval, enabling us to deliver unique solutions that transform healthcare.
Driving Clinical Development Excellence
HDT Bio’s commitment to excellence in clinical development is evident in its track record of establishing connections with leading academic medical centers, government organizations and foundations both domestically and internationally towards achieving clinical development success. By capitalizing on its previous experience, HDT Bio streamlines the development process, expedites clinical trials, and brings life-saving products to patients in need.
Global Value Creation
By providing safe, effective, and innovative products that improve lives around the world, HDT Bio is poised for significant growth through global clinical trials, government grants, and strategic partnerships. Making HDT Bio’s products widely available allows the company to make a meaningful difference on a global scale and realize success in multiple markets.
Achieving Global Health Objectives
HDT Bio’s strategy emphasizes an integrative approach, generating platform and product validation through international partnerships that accelerate pathways to patient access globally. By leveraging our platforms in oncology and infectious diseases, HDT Bio delivers life-changing solutions that have a positive impact on patients, healthcare providers, and society.
